Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice

Abstract Background The usefulness of the Oncomine Dx Target test (Oncomine Dx), a next‐generation sequencing (NGS) test, has already been proven in clinical trials. However, NGS requires high‐quality tumor samples and takes a long time to generate results. The feasibility of NGS for use in advanced...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Ryo Ariyasu, Ken Uchibori, Hironori Ninomiya, Shinsuke Ogusu, Ryosuke Tsugitomi, Ryo Manabe, Hiroaki Sakamaoto, Takehiro Tozuka, Hiroshi Yoshida, Yoshiaki Amino, Satoru Kitazono, Noriko Yanagitani, Kengo Takeuchi, Makoto Nishio
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2021-02-01
Serie:	Thoracic Cancer
Soggetti:	ALK‐immunohistochemistry Cobas EGFR mutation test Oncomine Dx Target test real‐world analysis turnaround time
Accesso online:	https://doi.org/10.1111/1759-7714.13786
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!